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Background: The impact of diabetes mellitus in patients with multiple system injuries remains obscure. This
study was designed to increase knowledge of outcomes of polytrauma in patients who have diabetes
mellitus.
Methods: Data from the Trauma Audit and Research Network was used to identify patients who had
suffered polytrauma during 2003 to 2011. These patients were filtered to those with known outcomes, then
separated into those with diabetes, those known to have other co-morbidities but not diabetes and those
known not to have any co-morbidities or diabetes. The data were analyzed to establish if patients with
diabetes had differing outcomes associated with their diabetes versus the other groups.
Results: In total, 222 patients had diabetes, 2,558 had no past medical co-morbidities (PMC), 2,709 had
PMC but no diabetes. The diabetic group of patients was found to be older than the other groups
(P <0.05). A higher mortality rate was found in the diabetic group compared to the non-PMC group (32.4%
versus 12.9%), P <0.05). Rates of many complications including renal failure, myocardial infarction, acute
respiratory distress syndrome, pulmonary embolism and deep vein thrombosis were all found to be higher
in the diabetic group.
Conclusions: Close monitoring of diabetic patients may result in improved outcomes. Tighter glycemic
control and earlier intervention for complications may reduce mortality and morbidity.
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Trauma itself is a pandemic which is projected to be
the second most common cause of disability adjusted
life years lost within the next thirteen years [1]. Trauma
accounts for about 16,000 deaths a day worldwide [2].
Polytrauma represents a more severe form of trauma
but currently there is no internationally standardized def-
inition of polytrauma. Recent literature has shown im-
proved reliability in defining polytrauma patients using an* Correspondence: pgiannoudi@aol.com
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unless otherwise stated.abbreviated injury score (AIS) [3] of greater than or equal
to three in more than one anatomical body region com-
pared to using the more conventional Injury Severity
Scores (ISS) alone [3-5]. Death from polytrauma using
AIS/ISS based data has shown an incidence in continental
Europe of 25 to 50 per 100,000 per year while in Canada
this number rises above 70 [2].
Much work has been done to identify how best to treat
patients with polytrauma including the introduction of the
universally used advanced trauma life support (ATLS) [6]
system. However, no large studies have yet to look specif-
ically at the impact of co-morbidities, and particularly
diabetes, on the outcome of this group of patients. In
the UK diabetes has an average prevalence of 4.45% with
just fewer than three million people currently diagnosedtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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have been shown to have an increased risk of infection
and longer hospital stay [8-11]. However, the impact of
diabetes in patients with multiple system injuries re-
mains obscure. The aim of this study, therefore, is to in-
vestigate whether the presence of diabetes is associated
with a higher mortality, increased length of hospital stay
and/or a higher incidence of peri-operative complica-
tions (adverse outcome) following polytrauma.
Methods
Data used were from the Trauma Audit and Research
Network (TARN) database in Manchester. TARN is a
non-profit organization that is funded by hospital sub-
scriptions from England and Wales. Approximately 95%
of hospitals in England and Wales are subscribed to the
network and supply data about their patient populations
relating to trauma. The data cover the patients’ initial
presentation and subsequent inpatient stay up until their
discharge. Data from each patient’s clinical record in-
clude details such as age, gender, injury scores (AIS and
ISS), body area injured, Glasgow Coma Scale (GCS)
score, heart rate, systolic blood pressure (SBP) on arrival,
lengths of stay in hospital and complications suffered.
The prospectively recorded data are then submitted
to TARN and used for benchmarking/research purposes
with the aim of improving acute trauma outcomes [12].TARN already has ethical approval (PIAG section 60)
for research on the anonymized data that is stored se-
curely on the University of Manchester server. The
TARN data collated over an eight year period between
2003 and 2011 were used. Patients were included if they
were deemed to have suffered polytrauma. As previously
discussed these patients presented with an AIS of 3 or
more in two or more body regions [5]. Patients were
then excluded if there was no documentation of their
outcome (survival versus non-survival). Further exclu-
sions were then applied to those whose past medical his-
tory was unclear, leaving only those who were known to
have either no past medical co-morbidities or known to
have co-morbidities including their diabetic status. Pre-
existing co-morbidities were defined as chronic obstruct-
ive pulmonary disease (COPD), hypertension, previous
myocardial infarction (MI) or renal impairment. For the
purposes of data analysis patients who met the inclusion
criteria were separated into three groups. Group 1 com-
prised patients who were known to have diabetes mellitus
(DM). Where appropriate this group was further sepa-
rated into those with insulin dependent diabetes mellitus
(IDDM) and non-insulin dependent diabetes mellitus
(NIDDM). Group 2 were patients who were known to
have other past medical co-morbidities (PMC) that did not
include diabetes. Group 3 patients were known to have no
co-morbidities including diabetes. This process is shown
in the algorithm below.
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of their demographic and presenting physiological charac-
teristics. Mortality in this study was defined as death within
30 days of injury from any cause within the initial hospital
presentation or during any subsequent re-admission for
management of the same injury. Further to all-cause mor-
tality, the three groups were studied in more detail in
order to see the incidence and mortality rates associated
with a number of specific co-morbidities or complications
(Table 1).Statistical analysis
The statistical analysis consisted of comparing trauma
patients’ baseline characteristics, such as age, gender, ISS,
and so on, among the three groups. Continuous variables,
that is, age, SBP, GCS, ISS, have a skewed distribution. For
our analysis we compared the medians of the three groups
because of skewness (Sk). These are the values of Sk
for some of the variables: GCS: Sk = −1.575 (moderate);
SBP: Sk = −0.165 (slight); ISS: Sk = 0.372(slight); pulse
rate: Sk = 0.042 (slight); length of stay (LOS): Sk =
1.091 (moderate); LOS ICU: Sk = 1.436 (moderate);
time to operation: Sk = 3.158 (extensive); time to death:
Sk = 1.019 (moderate). Due to the high number of variables
with moderate to extensive skewness non-parametric tech-
niques were used to test the null hypothesis that there is
no difference in the distribution of each of the variables
among the three groups. For this the Kruskal-Wallis test
has been used, which is the non parametric counterpart
of analysis of variance (ANOVA). For categorical vari-
ables the chi square test was used to test the hypothesis
of no association between the categorical variables and
the three groups. Interquartile ranges (IQR) for continu-
ous variables are displayed as well as 95% confidence
intervals for categorical variables. A P-value of 0.05 or
below is considered statistically significant (rejecting
the null hypothesis). The Statistical Package for Social
Sciences (SPSS) version 16 was used to carry out the
analyses.Table 1 Injury patterns and complications assessed for
association with co-morbidity, diabetes status and
outcome
Injury patterns Complications
Head AIS 3+ Pneumonia, Wound Infection, Sepsis, UTI
Abdo AIS 3+ Renal Failure
Chest AIS 3+ MI, Arrhythmia, Arrest
Extremity AIS 3+ ARDS, DVT, PE
Abdo, abdomen; AIS, abbreviated injury score; ARDS, acute respiratory distress
syndrome; DVT, deep vein thrombosis; PE, pulmonary embolism; UTI, urinary
tract infection.Results
Group numbers
Initial results from the TARN database generated 9,629
patients between 2003 and 2011 who suffered polytrauma
by our definition and had a known outcome for survival.
A total of 4,140 patients were then excluded due to in-
complete data regarding co-morbidities. The remaining
5,489 patients were divided into the three groups. Group
1 patients were confirmed to have diabetes mellitus, n = 222,
this group was subdivided when necessary into 1a, those with
non-insulin dependent diabetes mellitus (NIDDM), n = 143,
and 1b, those with insulin dependent diabetes mellitus
(IDDM), n = 79. Group 2 patients were those with con-
firmed past medical co-morbidities (PMC) but no dia-
betes, n = 2,709. Group 3 patients were confirmed to
have no PMC and no diabetes, n = 2,558. The preva-
lence of diabetes in the analyzed patients was 4%.
General observations
General analysis of the data is shown in Table 2. These
results look at initial observations as well as times to
theater/death/discharge. This study again shows the high
percentage of males involved in trauma; this was around
70% for the diabetic and PMC groups and higher at 78%
in the no PMC group.
There were no significant differences in the arrival obser-
vations of the patients in this review. These observa-
tions included ISS, GCS, SBP and heart rate. Injury severity
expressed as an ISS was equivocal through all groups for
the survivors. The ISS for non-survivors, however, was seen
to be lower in both the diabetic group and the PMC group
when compared to the non-PMC group (35 (Group1)
versus 35 (Group 2) versus 41 (Group 3), P <0.05).
Diabetic patients were found to spend more time in
hospital, two days longer than the PMC group and three
days longer than the non-PMC group (P < 0.05). The
LOS in ICU specifically, however, was not longer for dia-
betic patients.
Diabetic patients died later in their admission compared
with the other groups (42.9 versus 23.3 versus 10.7, hours,
P <0.05).
Diabetic patients were also seen to wait longer to get
to theater (12.3 versus 9.6 versus 7.9, hours, P <0.05).
The lowest all-cause mortality was seen in patients with
no PMC or DM (12.9%) and the highest seen in NIDDM
patients (33.6%) and IDDM patients (30.4%), P = <0.05.
This is shown in Table 3 along with average age of each
group.
Mechanism of injury
Tables 4 and 5 show the incidence and difference in mor-
tality based on the mechanism of injury. Injury mechanism
was investigated and separated into road traffic collision
(RTC), high fall, low fall, penetrating trauma and others.
Table 2 Polytrauma (AIS 3+ > =2 body regions, known outcome only) summary 2003 to 2011
Outcome observed Defined as PMC P-values
Diabetes Known PMC no diabetes Definitely no PMC
Gender Female 63 858 571 <0.001
% (95% CI) 28.4% (22.5 - 34.3) 31.7% (29.9 - 33.5) 22.3% (20.7 - 23.9)
Male 159 1851 1987
% (95% CI) 71.6% (65.7 - 77.5) 68.3% (66.5 - 70.1) 77.7% (76.1 - 78.7)
ISS Median ISS (IQR) 29 (25–38) 29 (22–38) 29 (22 - 38) 0.801
GCS on arrival Median GCS (IQR) 14 (11–15) 15 (12–15) 15 (12 - 15) 0.231
SBP on arrival Median SBP (IQR) 132 (108–154) 128 (108–146) 128 (110 - 145) 0.220
Pulse rate on arrival Median HR (IQR) 94.5 (80–110) 93 (77–111) 95 (79 - 114) 0.058
Days in hospital Median LOS (IQR) 17 (4–37.3) 15 (6–34) 14 (6 - 27) 0.005
Hours to death Median time to death(IQR) 42.9 (6.8 - 130.4) 23.3 (3.7 - 125.8) 10.7 (1.9 - 95.9) <0.001
Number of operations Median number of operations (IQR) 2 (1–3) 2 (1–3) 2 (1–3) 0.484
Hours to operation (hours) Median time to theater (IQR) 12.3 (3.6 - 45.8) 9.6 (3.6 - 46.9) 7.9 (3.1 - 27.5) 0.02
Critical care stay No 83 1047 966 0.779
% (95% CI) 37.4 (31–43.8) 38.6 (36.8 - 40.5) 37.8 (35.9 - 39.6)
Yes 139 1662 1592
% (95% CI) 62.6 (56.2 - 69) 61.4 (59.5 - 63.2) 62.2 (60.4 - 64.1)
Days in critical care Median LOS ICU (IQR) 3 (0–10.8) 3 (0–10) 3 (0–8) 0.147
Where appropriate values are presented in %s. AIS, Abbreviated Injury Score; CI, confidence interval; GCS, Glasgow Coma Score; HR, heart rate; IQR, interquartile
range; ISS, Injury Severity Score; LOS, length of stay; PMC, past medical co-morbidities; SBP, systolic blood pressure.
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by mechanism; however, no single mechanism of injury
has a statistically significant difference in mortality when
comparing the three groups. Diabetic patients had a low
incidence of RTC and penetrating trauma and a signifi-
cantly higher incidence of fall from a height causing
polytrauma.
Injury distribution
For patients with a head injury of AIS ≥ 3, mortality was
higher in diabetic (group 1) patients compared to group
2 and more than double that of group 3 (43.9 versus 24.4
versus 19% (group 3), P <0.05). The incidence of head in-
jury was approximately 55% to 60% in all three groups.Table 3 Polytrauma by diabetic co morbid status (AIS 3+ ≥2 b
2011
Sub-groups Defined as Diabetes
Outcome
Alive D
Diabetes: Insulin dependent No 95
(95% CI) 66.4 (58.7 to 58.7) 33.6 (25
Yes 55
(95% CI) 69.6 (59.5 to 79.8) 30.4 (20
Age Median age (years) 58.1
IQR 42 to 70 60
Where appropriate values are presented in %s. AIS, Abbreviated Injury Score; CI, coDiabetic patients were not seen to have a difference
in mortality from abdominal injuries (AIS > 3); however,
the incidence was significantly lower in diabetic patients
compared with the other groups (11.3 versus 18.5 versus
23.4%, respectively; P <0.05).
The mortality of chest injuries in diabetic patients ap-
pears to be higher than the other groups (32.9 versus 22.5
versus 14.4%, respectively); however, the comparable num-
ber of these patients in this study was insufficient to infer
a global trend. The incidence of chest injuries was ap-
proximately 75% for all groups.
The mortality of patients who suffered extremity injuries
of AIS ≥ 3 as part of their polytrauma was comparable,
with a slightly higher mortality for the diabetic patientsody regions, known outcome only) summary 2003 to
Known PMC no diabetes Definitely no PMC P-values
Outcome Outcome
ead Alive Dead Alive Dead
48 2156 553 2229 329 N/A
.8 to 41.3) 79.6% 20.4% 87.1% 12.9%
24
.2 to 40.5)
74.3 44.5 63.6 28.6 27.7 <0.001
to 81 29 to 61 43 to 82 20 to 43 20 to 46
nfidence interval; IQR, interquartile range; PMC, past medical co-morbidities.
Table 4 Prevalence of injury to different body regions, mechanisms of and complications from polytrauma
Injury/Outcome Present PMC P-values
Diabetes Known PMC no diabetes Definitely no PMC
Head AIS 3+ No 90 1174 1122 0.622
% (95% CI) 40.5 (34.1 to 47) 43.3 (41.5 to 45.2) 43.9 (41.9 to 45.8)
Yes 132 1535 1436
% (95% CI) 59.5 (53 to 65.9) 56.7 (54.8 to 58.5) 56.1 (54.2 to 58.1)
Abdo AIS 3+ No 197 2208 1959 <0.001
% (95% CI) 88.7 (84.6 to 92.9) 81.5 (80 to 83) 76.6 (74.9 to 78.2)
Yes 25 501 599
% (95% CI) 11.3 (7.1 to 15.4) 18.5 (17 to 20) 23.4 (21.8 to 25.1)
Chest AIS 3+ No 55 666 615 0.890
% (95% CI) 24.8 (19.1 to 30.5) 24.6 (23 to 26.2) 24 (22.4 to 25.7)
Yes 167 2043 1943
% (95% CI) 75.2 (69.5 to 80.9) 75.4 (73.8 to 77) 76 (74.3 to 77.6)
Extremity AIS 3+ No 114 1340 1248 0.719
% (95% CI) 51.4 (44.8 to 57.9) 49.5 (47.6 to 51.3) 48.8 (46.9 to 50.7)
Yes 108 1369 1310
% (95% CI) 48.6 (42.1 to 55.2) 50.5 (48.7 to 52.4) 51.2 (49.3 to 53.1)
Any complication No 115 1472 1065 <0.001
% (95% CI) 51.8 (45.2 to 58.4) 54.3 (52.5 to 56.2) 41.6 (39.7 to 43.5)
Yes 107 1237 1493
% (95% CI) 48.2 (41.6 to 54.8) 45.7 (43.8 to 47.5) 58.4 (56.5 to 60.3)
ARDS, DVT, PE No 210 2644 2497 0.019
% (95% CI) 94.6 (91.6 to 97.6) 97.6 (97 to 98.2) 97.6 (97 to 98.2)
Yes 12 65 61
% (95% CI) 5.4 (2.4 to 8.4) 2.4 (1.8 to 3) 2.4 (1.8 to 3)
Pneumonia, Wound
infection, Sepsis, UTI
No 199 2483 2390 0.015
% (95% CI) 89.6 (85.6 to 93.6) 91.7% (90.6 to 92.7) 93.4% (92.5 to 94.4)
Yes 23 226 168
% (95% CI) 10.4 (6.4 to 14.4) 8.3 (7.3 to 9.4) 6.6 (5.6 to 7.5)
Renal failure No 215 2671 2539 0.002
% (95% CI) 96.8 (94.5 to 99.1) 98.6 (98.2 to 99) 99.3 (98.9 to 99.6)
Yes 7 38 19
% (95% CI) 3.2 (0.9 to 5.5) 1.4 (1 to 1.8) 0.7 (0.4 to 1.1)
MI, arrhythmia, arrest No 209 2590 2504 <0.001
% (95% CI) 94.1 (91.1 to 97.2) 95.6 (94.8 to 96.4) 97.9 (97.3 to 98.4)
Yes 13 119 54
% (95% CI) 5.9 (2.8 to 8.9) 4.4 (3.6 to 5.2) 2.1 (1.6 to 2.7)
Injury mechanism RTC (95% CI) 117 1437 1843 <0.001
52.7 (46.1 to 59.3) 53 (53 to 54.9) 72.0
High Fall (95% CI) 52 673 358
23.4 (17.8 to 29) 24.8 (23.2 to 26.4) 14 (12.7 to 15.3)
Low Fall (95% CI) 41 302 60
18.5 (13.4 to 23.6) 11.1 (9.9 to 12.3) 2.3 (1.7 to 2.9)
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Table 4 Prevalence of injury to different body regions, mechanisms of and complications from polytrauma (Continued)
Other (95% CI) 10 200 188
4.5 (1.8 to 7.2) 7.4 (6.4 to 8.4) 7.3 (6.3 to 8.3)
Penetrating trauma (95% CI) 2 97 109
0.9 (0 to 2.1) 3.6 (2.9 to 4.3) 4.3 (3.5 to 5.1)
Total 222 2709 2558
Where appropriate values are presented in %s. Abdo, abdomen; AIS, Abbreviated Injury Score; ARDS, acute respiratory distress syndrome; CI, confidence interval;
DVT, deep vein thrombosis; MI, myocardial infarction; PE, pulmonary embolism; RTC, road traffic collision; UTI, urinary tract infection.
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sus 10.4%, respectively). The incidence was similar among
groups at approximately 50%.
Complications
Tables 4 and 5 also show the mortality of each group re-
lated to certain complications. The overall mortality of
the diabetic group from any given complication, once
developed, appears higher than the other groups (35.5
versus 22.7 versus 12.5%), respectively. However, the in-
cidence of complications is lower in both the DM group
and the known PMC group compared with the group
with no PMC (48.2 versus 45.7 versus 58.4%, respectively;
P <0.05).
There was 50% mortality for the 12 diabetic patients
who developed ARDS, PE or DVT, double that of the
PMC group and five times that of the no PMC group
(50 versus 24.6 versus 9.8%, respectively). However, des-
pite this trend the low number of patients seen in each
group prevents us from inferring the same trends for the
population parameters. A similar incidence of ARDS,
DVT and PE was seen in the PMC and no PMC groups
but when compared with the diabetic group, it was ob-
served that diabetic patients are 2.25 times more likely
to develop ARDS, DVT or PE (5.4 versus 2.4 versus
2.4%, respectively; P <0.05).
In our data sample, mortality from pneumonia, wound
infection, sepsis or UTI was similar in the diabetic and
PMC groups but both appeared higher than that of the
no PMC group. The incidence, however, of pneumonia,
wound infection, sepsis or UTI was highest in diabetic
patients (10.4 versus 8.3 versus 6.6%, respectively; P <0.05).
Patients who developed renal failure appeared more
likely to die if they were diabetic (42.9 versus 34.2 versus
15.8%, respectively). The incidence was also much higher
in the diabetic group, more than double that of the PMC
group and 4.5 times higher than that of the no PMC
group (3.2 versus 1.4 versus 0.7%, respectively; P <0.05).
The mortality of patients who suffered MI, arrhythmia
or arrest was found to be higher in patients in the no
PMC group (69.2% versus 65.5 versus 74.1%, respectively;
P <0.05); however, the incidence of these complications
was 2.8 times higher in the diabetic patients than in theno PMC group (5.9 versus 4.4 versus 2.1%, respectively;
P <0.05).
Table 6 shows the results of a mortality prediction model.
This shows that increasing age and ISS is linked with in-
creasing mortality. In this study, pre-existing medical
conditions do not appear to cause a statistical increase
in mortality. However, the presence of diabetes, even
when accounting for age, ISS and GCS, does create an
increase in the prediction of mortality with an odds ra-
tio (OR) of 1.64 (P <0.05).
Discussion
Although many different forms of diabetes exist, the dis-
ease is generally classified as either IDDM (Type 1) or
NIDDM (Type 2) [7]. These classifications have a major
impact on disease progression over many years; however,
for the majority of this study we have focused on dia-
betes as a single disease state while examining its effects
over the relatively short period of treating patients who
have suffered polytrauma.
The lower rate of diabetes seen in this analysis versus
the UK average [7] may be explained by the higher age
of diabetic patients seen in the review. Previous studies
have not only shown an average age of polytrauma of
around 40 but also a tendency for patients involved in
polytrauma to have a younger age distribution [13-15]. It
is generally taken that younger patients are also more
likely to be involved in high energy accidents [13].
A mortality of more than 30% seen in diabetic patients
is similar to that seen in previous studies looking at elderly
patients involved in polytrauma [16] and would be con-
sistent with the average age of diabetic non-survivors,
74.3 years. However, the age adjusted prediction model
shows diabetes to be an independent predictor of in-
creased mortality. The mortality of IDDM sufferers was
also more than 30% and would seem to implicate an even
higher level of relative mortality in these conversely youn-
ger patients.
Linking previous literature as well as the results of our
review indicates two separate pathways leading to poor
outcomes for diabetic patients. The first pathway shows
a high mortality in patients who have suffered head
injury AIS ≥3 in the context of polytrauma. The second
Table 5 Mortality by body region injured, complications and mechanism of injury
Injury/Complication Present/Mechanism Diabetes P-values Known PMC no diabetes P-values Definitely no PMC P-values
Outcome Outcome Outcome
Alive Dead Alive Dead Alive Dead
Head AIS 3+ Yes (95% CI) 74 58 <0.001 1161 374 <0.001 1163 273 <0.001
56.1 (47.6 - 64.5) 43.9 (35.5 - 52.4) 75.6 (13.2 - 17.3) 24.4 (22.2 - 26.5) 81 (3.7 - 6.3) 19 (17 - 21)
Abdo AIS 3+ Yes (95% CI) 19 6 0.466 373 128 0.002 523 76 0.944
76 (59.3 - 92.7) 24 (7.3 - 40.7) 74.5 (70.6 - 78.3) 25.5 (21.7 - 29.4) 87.3 (84.6 - 90) 12.7 (10 - 15.4)
Chest AIS 3+ Yes (95% CI) 112 55 0.911 1583 460 <0.001 1664 279 <0.001
67.1 (59.9 - 74.2) 32.9 (25.8 - 40.1) 77.5 (75.7 - 79.3) 22.5 (20.7 - 24.3) 85.6 (84.1 - 87.2) 14.4 (12.8 - 15.9)
Extremity AIS 3+ Yes
(95% CI) 84 24 0.003 1114 255 0.022 1174 136 <0.001
77.8 (69.9 - 85.6) 22.2 (14.4 - 30.1) 81.4 (79.3 - 83.4) 18.6 (16.6 - 20.7) 89.6 (88 - 91.3) 10.4 (8.7 - 12)
Any complication Yes (95% CI) 69 38 0.422 956 281 0.007 1306 187 0.588
64.5 (55.4 - 73.6) 35.5 (26.4 - 44.6) 77.3 (74.9 - 79.6) 22.7 (20.4 - 25.1) 87.5 (85.8 - 89.2) 12.5 (10.8 - 14.2)
ARDS, DVT, PE Yes (95% CI) 6 6 0.308 49 16 0.487 55 6 0.602
50 (21.7 - 78.3) 50 (21.7 - 78.3) 75.4 (64.9 - 85.9) 24.6 (14.1 - 35.1) 90.2 (82.7 - 97.6) 9.8 (2.4 - 17.3)
Pneumonia, wound
infection, sepsis, UTI
Yes (95% CI) 18 5 0.357 181 45 0.913 153 15 0.145
78.3 (61.4 - 95.1) 21.7 (4.9 - 38.6) 80.1 (74.9 - 85.3) 19.9 (14.7 - 25.1) 91.1 (86.8 - 95.4) 8.9 (4.6 - 13.2)
Renal Failure Yes 4 3 25 13 0.055 16 3
65.8% 34.2% 84.2% 15.8%
(50.7 - 80.9) (19.1 - 49.3) (60.4 - 96.6)a (3.4 - 39.6)a
MI, arrhythmia, arrest Yes 4 9 41 78 <0.001 14 40 <0.001
34.5% 65.5% 25.9% 74.1%
(25.9 - 43) (57 - 74.1) (14.2 - 37.6) (62.4 - 85.8)
Injury mechanism RTC (95% CI) 85 32 0.194a 1173 264 0.001 1608 235 0.787
72.6% 27.4% 81.6% 18.4% 87.2% 12.8%
(64.5 - 80.7) (19.3 - 35.5) (79.6 - 78.3) (13.4 - 33.1) (85.7 - 88.7) (11.3 - 14.3)
High fall (95% CI) 31 21 513 160 311 47
59.6% 40.4% 76.2% 23.8% 86.9% 13.1%
(46.3 - 72.9) (19.3 - 35.5) (73 - 79.4) (20.6 - 27) (83.4 - 90.4) (9.6 - 16.6)
Tebby
et
al.BM
C
M
edicine
2014,12:111
Page
7
of
11
http://w
w
w
.biom
edcentral.com
/1741-7015/12/111
Table 5 Mortality by body region injured, complications and mechanism of injury (Continued)
Low fall (95% CI) 24 17 225 77 50 10
58.5% 41.5% 74.5% 25.5% 83.3% 16.7%
(43.4 - 73.6) (26.4 - 56.6) (69.6 - 79.4) (20.6 - 30.4) (73.9 - 91.9) (7.3 - 26.1)
Other 8 2 159 41 162 26
79.5% (73.9 - 85.1) 20.5% (14.9 - 26.1) 86.2% (81.3 - 91.1) 13.8% (8.9 - 18.7)
Penetrating trauma 2 0 86 11 98 11
88.7% (82.4 - 95) 11.3% (5 - 17.6) 89.9% (84.2 - 95.6) 10.1% (4.4 - 15.8)
Where appropriate values are presented in %s. aP-value for such analyses should not be interpreted due to the small number of patients. Abdo, abdomen; AIS, Abbreviated Injury Score; ARDS, acute respiratory distress
syndrome; CI, confidence interval; DVT, deep vein thrombosis; MI, myocardial infarction; PE, pulmonary embolism; RTC, road traffic collision; UTI, urinary tract infection.
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Table 6 Model predicting death
Variables Odds ratio P-value 95% CI OR
Age 1.06 <0.001 1.05 1.07
ISS 1.08 <0.001 1.07 1.09
GCS 0.79 <0.001 0.77 0.81
Pre-existing medical condition 1.25 0.09 0.97 1.63
Diabetes (yes) 1.64 0.026 1.06 2.53
Gender (male) 1.91 0.066 0.96 3.78
Age by gender interaction 0.99 0.107 0.98 1.00
CI, confidence interval; GCS, Glasgow Coma Score; ISS, Injury Severity Score.
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the associated mortality that there appears to be but has
not been statistically proven in this review.
It has been established that both early hyperglyaemia
and insulin deficiency have been shown to increase mor-
tality from traumatic brain injury, especially in diabetic pa-
tients [17,18]. The mortality rates in those studies, even
for diabetic patients, show much lower rates of death
(approximately 15% to 20%) than are observed in our
results (>40%). This is likely due to the increased neuro-
hormonal activity associated with polytrauma itself
which will further increase cortisol levels and, therefore,
hyperglycemia and insulin requirements [19]. This in-
crease in blood glucose after polytrauma is not exclusive
to diabetic patients suggesting that the increasing mor-
tality seen in this group may be related to other changes
associated with diabetes, such as the long term damage
to the microvasculature associated with chronic diabetes
[20]. In this case, the NIDDM patients would suffer more
so than the IDDM patients. While there is no clear sec-
ondary mechanism for the poor outcome of diabetic pa-
tients, previous animal studies have shown that alloxan
diabetes can directly change the level of vascular supply to
the brain in head injuries in rat models [21]. Post mortem
examinations of patients with dementia have also shown
cases where untreated diabetic patients have an increased
amyloid plaque load that was not seen in non-diabetic
patients [22]. Identification of a reversible or treatable
change in the diabetic brain may improve outcomes in
this group but these changes would be part of improved
secondary prevention in diabetes and not related to treat-
ing acute head injury. Certainly, these data suggest that all
diabetic patients with a head injury would benefit from an
insulin sliding scale with scope for recommendation that
all patients who have a head injury and deranged blood
glucose should have aggressive correction of hypergly-
cemia with insulin. Furthermore, in the acute setting, it
has been shown on ICU that an increase in complications
can be related to higher blood glucose levels [23-25]. This
association between hyperglycemia and complications
may explain why diabetic patients have a similar incidence
of complications compared to the other groups despitehaving been involved in lower energy mechanisms. This in
turn leads to the second pathway of mortality.
The second pathway leads to late deaths from increased
rates of complications in diabetic patients and is separate
from the mechanism of injury. The body areas affected
may well dictate the types of complications expected and
allow the early identification and aggressive treatment of
certain injuries in diabetic patients. For example, a dia-
betic patient with a chest injury of AIS ≥ 3 may benefit
from earlier management to prevent chest sepsis. The
higher rate of complications appears in this study to be
directly related to diabetes. Diabetes alone has previously
been implicated as an independent risk factor for compli-
cations, especially in elderly patients in polytrauma [11].
No comment has been made previously as to which com-
plications are more damaging or how to reduce the rates
of mortality from these complications. Implementation of
sliding scales to reduce hyperglycemia in ICU may reduce
the rate of complications and the mortality rates seen. It
is, however, likely that the majority of complications
within the diabetic patient group are a result of their poor
physiological status compared with other patients of similar
age and injury. It has been suggested that diabetic patients
have a reduced immune function compared to non-diabetic
patients, especially looking at phagocytic function [26].
This may directly lead to the higher rate of infective com-
plications, such as pneumonia and urinary sepsis, as well
as the associated increased mortality. These patients may
benefit from earlier intervention for the prevention of in-
fection. For chest injuries diabetics may benefit from more
intensive physiotherapy with greater pain control in order
to maximize respiratory function. The earlier use of anti-
biotics to aid the immune system may also be beneficial.
Diabetes has been shown by Kateros et al. to be an inde-
pendent factor for developing kidney disease after ortho-
pedic input which did not revert back to pre-morbid level
[27]. This has certainly been shown to overlap into the
polytrauma setting. The judicious use of nephrotoxic
medicines and avoiding hypovolemia in diabetic patients
may well prevent acute kidney injury and death from renal
failure in this group. Diabetes is also related to increasing
obesity and increased end-organ damage with these
changes worsening with the duration of the patients’
diabetes [28,29]. These changes will lead to a lower
physiological reserve both for survival and rehabilitation.
It would appear that the most beneficial way of preventing
complications and death in diabetic patients is early iden-
tification, closer monitoring and earlier intervention.
The tendency of diabetic patients to have suffered poly-
trauma from a low energy injury may be causing them to
spend more time in emergency departments. It may only
be after later assessment that these patients are identified
to be suffering from polytrauma. This would provide one
cause for their longer waiting times to go to theater. These
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of the above-mentioned pathways. The increased time to
death and lower rate of severe abdominal trauma or pene-
trating injuries (AIS ≥ 3) in the diabetic group would seem
to indicate a lower rate of death by hemorrhage which
would be expected to lead to a quicker death. The diabetic
patients are also less likely to die quickly due to their in-
creased tendency to have suffered polytrauma from a low
energy injury, that is, low fall. Lower energy mechanisms
are less likely to lead to injuries that would cause death in
the acute phase. This further emphasizes that diabetic pa-
tients are more likely to develop, and die from, complica-
tions with lower energy injuries. With improved care for
patients in the acute phase in hospital the death rates from
lower energy injuries should be lower; the reverse, how-
ever, is seen in the diabetic group.
The aforementioned lower physiological reserve may
also contribute to the diabetic patients spending longer
in hospital than either of the other patient groups. This
is despite spending a similar amount of time in ICU
than the other groups. The increased stay on the ward is
unlikely to be due solely to their increased age given that
the PMC group, which also has an increased median
age, did not have a similar increase in stay. The presence
of diabetes would appear to be an independent factor at
this stage for increasing the overall length of stay. This,
in part, may be due to their increased rate of complications.
However, in order to allow a step down to ward-level
care these complications would need to be improving.
Re-establishing safe control of blood glucose prior to dis-
charge in diabetic patients may also be requiring extra
time in hospital, although, neither of these explanations
would explain the similar rates seen in LOS in ICU. This
indicates the presence of a beneficial management that is
occurring in the ICU environment. Certainly, the majority
of studies looking at glycemic control occur within the
ICU environment [23-25] and may reflect a greater moni-
toring of glycemic control that is not possible in the ward
environment. Patients, therefore, may benefit from spend-
ing more time at higher levels of care in order to prevent
longer in-patient stays.
The main strength of this study is the large numbers
involved in, and the quality of the data from, the TARN
database. Further strengths include the fact that the data
are collected prospectively and that the data are from
multiple centers within England and Wales. Multiple pa-
rameters are recorded by the centers involved and access
to the database for those centers for research purposes
encourages participation. The loss of 4,140 patients from
the original data set of 9,629 due to incomplete docu-
mentation of pre-existing co-morbidities does create a
limitation to the results and observations in the paper.
Analysis of this lost group compared to those included
shows that the excluded group presented with a higherISS and had a higher mortality. They were also more
likely to have suffered from a head injury. It may be that
this group of patients was more likely to die earlier be-
fore their collateral history could be obtained. The per-
centage by year of patients lost was also examined; this
showed that an average of 11% of patients had incomplete
data regarding PMC. However, this number is reducing
and was only 5% in 2011, therefore, having a smaller im-
pact on the results seen.
Due to the low prevalence of diabetes, the loss of data
could have led to some findings not achieving statistical
significance. This is most noticeable when looking at mor-
tality rates from complications in diabetic patients, which
appear higher but have not been statistically proven. The
database also relies on the centers to assess and input data
correctly. This may be particularly difficult when using the
AIS which already requires a subjective assessment of
each patient’s injury [5]. This study is further limited by
the use of a single database without incorporating data
and findings of previous reviews of polytrauma patients.
In conclusion, the data analyzed have shown that dia-
betic patients have a mortality of more than 30% after
suffering polytrauma and an increased overall mortality
even when matched against age and sex. Diabetes was
found to be an independent factor for increasing mortal-
ity in polytrauma, OR of 1.64, P <0.05. Diabetic patients
are noted to have a significantly higher mortality rate
from head injury in the context of polytrauma compared
to the non-PMC group, OR 1.80 (1.30 to 2.51, P <0.05).
The rate of mortality from head injury in diabetic pa-
tients in the context of polytrauma appears significantly
higher than the mortality of isolated head injury in diabetic
patients. Other important findings can be summarized as
follows: they have a higher mortality after suffering poly-
trauma from a low fall versus the non-PMC group, OR =
2.49 (1.03 to 5.98, P <0.05); they are four times more likely
to develop renal failure than patients with no-PMC, OR =
4.25 (1.77 to 10.21, P <0.05); they are more than 2.5 times
more likely to suffer an MI, arrhythmia or arrest versus
non-PMC patients, OR = 2.77 (1.49 to 5.16, P <0.05); they
are more than two times more likely to suffer from ARDS,
DVT or PE versus non-PMC patients, OR = 2.27 (1.20
to 4.27, P <0.05); they are nearly three times more likely
to die if they suffer complications while in hospital com-
pared to patients with no PMC, OR = 2.84 (1.90 to 4.23,
P <0.05); and they spend on average two more ward
days in hospital than other patients.
It would seem logical that the process of hyperglycemia
may be responsible for some of the poor outcomes seen in
diabetic patients. However, previous studies looking into
glycemic control have not always focused directly on both
type 1 and type 2 diabetic patients [23-25]. In order to
progress from this study, a question must be asked as to
how we can limit or eliminate these changes, for example,
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patients in ICUs and on the ward levels of complications
along with the underlying chronic physiological changes
in diabetic patients that make them particularly susceptible
to complications from polytrauma and, as such, should be
monitored closely with a low threshold for implementing
early treatment.
Conclusions
A higher rate of overall mortality and rate of complica-
tions were noted in the context of polytrauma with dia-
betic patients. Early identification and targeted monitoring
of diabetic patients may result in improved outcomes for
these patients.
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